Protocols for High-Risk Pregnancies. Группа авторов

href="#ucbe8410c-f2bf-5bf8-b1e6-757ae57f7207">PROTOCOL 38: Nausea and Vomiting Clinical significance Diagnosis and pathophysiology Differential diagnosis Treatment Complications Recurrence risk Conclusion Suggested reading PROTOCOL 39: Fetal Death and Stillbirth Overview Pathophysiology and etiology Diagnosis Treatment Diagnostic evaluation Follow‐up Suggested reading PROTOCOL 40: Abnormal Amniotic Fluid Volume Overview Physiology of normal amniotic fluid volume Amniotic fluid production Amniotic fluid removal Oligohydramnios Polyhydramnios Suggested reading PROTOCOL 41: Fetal Growth Restriction Definition and clinical significance Etiology Screening Surveillance Management Outcome Prevention Conclusion Suggested reading PROTOCOL 42: Rh and Other Blood Group Alloimmunizations Overview Pathophysiology Management of the first alloimmunized pregnancy (Figure 42.1) Management of a subsequent alloimmunized pregnancy Treatment Outcome and follow‐up Prevention Conclusion Suggested reading PROTOCOL 43: Preterm Labor Clinical significance Pathophysiology Diagnosis Treatment Complications Follow‐up Conclusion Suggested reading PROTOCOL 44: Prevention of Preterm Birth Clinical significance Pathophysiology and antecedents of preterm birth Management Conclusion Suggested reading PROTOCOL 45: Premature Rupture of the Membranes Overview Pathophysiology Clinical implications Diagnosis Evaluation Management Special circumstances Prevention of recurrent preterm PROM Suggested reading PROTOCOL 46: Indicated Late‐Preterm and Early‐Term Deliveries Clinical significance Pathophysiology Diagnosis Management Complications Follow‐up and prevention Conclusion Suggested reading PROTOCOL 47: Chorioamnionitis Overview Definitions and clinical presentation Epidemiology Pathophysiology